Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5
- PMID: 16183037
- DOI: 10.1016/j.bcp.2005.08.009
Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5
Abstract
Oxidative metabolism of bilirubin (BR) -- a breakdown product of haem with cytoprotective and toxic properties -- is an important route of detoxification in addition to glucuronidation. The major enzyme(s) involved in this oxidative degradation are not known. In this paper, we present evidence for a major role of the hepatic cytochrome P450 2A5 (Cyp2a5) in BR degradation during cadmium intoxication, where the BR levels are elevated following induction of haem oxygenase-1 (HO-1). Treatment of DBA/2J mice with CdCl(2) induced both the Cyp2a5 and HO-1, and increased the microsomal BR degradation activity. By contrast, the total cytochrome P450 (CYP) content and the expression of Cyp1a2 were down-regulated by the treatment. The induction of the HO-1 and Cyp2a5 was substantial at the mRNA, protein and enzyme activity levels. In each case, the up-regulation of HO-1 preceded that of Cyp2a5 with a 5-10h interval. BR totally inhibited the microsomal Cyp2a5-dependent coumarin hydroxylase activity, with an IC(50) approximately equal to the substrate concentration. The 7-methoxyresorufin 7-O-demethylase (MROD) activity, catalyzed mainly by the Cyp1a2, was inhibited up to 36% by BR. The microsomal BR degradation was inhibited by coumarin and a monoclonal antibody against the Cyp2a5 by about 90%. Furthermore, 7-methoxyresorufin, a substrate for the Cyp1a2, inhibited BR degradation activity by approximately 20%. In sum, the results strongly suggest a major role for Cyp2a5 in the oxidative degradation of BR. Secondly, the coordinated up-regulation of the HO-1 and Cyp2a5 during Cd-mediated injury implicates a network of enzyme systems in the maintenance of balancing BR production and elimination.
Similar articles
-
Mitochondrial targeting of bilirubin regulatory enzymes: An adaptive response to oxidative stress.Toxicol Appl Pharmacol. 2015 Jan 1;282(1):77-89. doi: 10.1016/j.taap.2014.11.010. Epub 2014 Dec 3. Toxicol Appl Pharmacol. 2015. PMID: 25478736
-
Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.Toxicol Appl Pharmacol. 2013 Jul 15;270(2):129-38. doi: 10.1016/j.taap.2013.04.013. Epub 2013 Apr 26. Toxicol Appl Pharmacol. 2013. PMID: 23628428
-
Inducible bilirubin oxidase: a novel function for the mouse cytochrome P450 2A5.Toxicol Appl Pharmacol. 2011 Nov 15;257(1):14-22. doi: 10.1016/j.taap.2011.08.011. Epub 2011 Aug 17. Toxicol Appl Pharmacol. 2011. PMID: 21871474
-
Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.Curr Drug Metab. 2013 Jan;14(1):137-50. Curr Drug Metab. 2013. PMID: 22497566 Review.
-
CYP2A5 induction and hepatocellular stress: an adaptive response to perturbations of heme homeostasis.Curr Drug Metab. 2011 Feb;12(2):186-97. doi: 10.2174/138920011795016845. Curr Drug Metab. 2011. PMID: 21395539 Review.
Cited by
-
Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.Malar J. 2010 Mar 22;9:81. doi: 10.1186/1475-2875-9-81. Malar J. 2010. PMID: 20307316 Free PMC article.
-
Cytochrome P450s and Alcoholic Liver Disease.Curr Pharm Des. 2018;24(14):1502-1517. doi: 10.2174/1381612824666180410091511. Curr Pharm Des. 2018. PMID: 29637855 Free PMC article. Review.
-
Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.Redox Biol. 2013 Aug 24;1(1):433-40. doi: 10.1016/j.redox.2013.08.003. eCollection 2013. Redox Biol. 2013. PMID: 24191237 Free PMC article.
-
Regulation of Cytochrome P450 2a5 by Artemisia capillaris and 6,7-Dimethylesculetin in Mouse Hepatocytes.Front Pharmacol. 2021 Nov 22;12:730416. doi: 10.3389/fphar.2021.730416. eCollection 2021. Front Pharmacol. 2021. PMID: 34880749 Free PMC article.
-
Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.Front Pharmacol. 2012 May 18;3:89. doi: 10.3389/fphar.2012.00089. eCollection 2012. Front Pharmacol. 2012. PMID: 22629246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases